Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice

BMC Biotechnology

Volumn 10, Issue , 2010, Pages

  Laguía Becher, Melina ^a   Martín, Valentina ^b   Kraemer, Mauricio ^a   Corigliano, Mariana ^a   Yacono, María L ^a   Goldman, Alejandra ^b   Clemente, Marina ^a  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AGROBACTERIUM TUMEFACIENS; AGROINFILTRATION; APOPLASTS; BINARY EXPRESSION VECTOR; CODON OPTIMIZATION; ENDOPLASMIC RETICULUM; EXPRESSION LEVELS; IMMUNE RESPONSE; LEAF EXTRACTS; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; SUBCELLULAR TARGETING; TOBACCO LEAVE; TOXOPLASMA GONDII; TRANSIENT EXPRESSION;

ANIMALS; ANTIGENS; ESCHERICHIA COLI; GENE ENCODING; GENE EXPRESSION; IMMUNIZATION; OPTIMIZATION; TOBACCO;

PROTEINS;

DNA VACCINE; FREUND ADJUVANT; GAMMA INTERFERON; MESSENGER RNA; PLANT EXTRACT; RECOMBINANT PROTEIN; RECOMBINANT SAG1 PROTEIN; SAG1 PROTEIN; TOBACCO EXTRACT; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; SAG1 ANTIGEN, TOXOPLASMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPLAST; ARTICLE; BRAIN CYST; CELLULAR IMMUNITY; CODON USAGE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOASSAY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT LEAF; PROTEIN LOCALIZATION; PROTEIN TARGETING; TOBACCO; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; C3H MOUSE; C57BL MOUSE; CODON; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; TH1 CELL; TOXOPLASMA; TRANSGENIC PLANT;

AGROBACTERIUM TUMEFACIENS; ANIMALIA; ESCHERICHIA COLI; MUS; NICOTIANA TABACUM; TOXOPLASMA GONDII;

ANIMALS; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CODON; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; INTERFERON-GAMMA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; TH1 CELLS; TOBACCO; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 77954560597     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-10-52     Document Type: Article

References (59)

1. Floss DM, Falkenburg D, Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res 2007, 16:315-332. 10.1007/s11248-007-9095-x, 17436059.
2. Yusibov V, Rabindran S. Recent progress in the development of plant derived vaccines. Expert Rev Vaccines 2008, 7:1173-1183. 10.1586/14760584.7.8.1173, 18844592.
3. Doran PM. Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol 2006, 24:426-432. 10.1016/j.tibtech.2006.06.012, 16843560.
4. Streatfield SJ. Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 2007, 5:2-15. 10.1111/j.1467-7652.2006.00216.x, 17207252.
5. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30:1217-1258. 10.1016/S0020-7519(00)00124-7, 11113252.
6. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
7. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006, 21:458-472. 10.1016/j.reprotox.2005.10.006, 16311017.
8. Dubey JP, Schlafer DH, Urban JF, Lindsay DS. Lesions in fetal pigs with transplacentally-induced toxoplasmosis. Vet Pathol 1990, 27:411-418. 10.1177/030098589902700605, 2278129.
9. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet Res 1998, 29:289-310.
10. Wyss R, Sager H, Müller N, Inderbitzin F, König M, Audigé L, Gottstein B. The occurrence of Toxoplasma gondii and Neospora caninum as regards meat hygiene. Schweiz Arch Tierheilkd 2000, 142:95-108.
11. Qu D, Wang S, Cai W, Du A. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine 2008, 26:4541-4548. 10.1016/j.vaccine.2008.06.030, 18590785.
12. Bhopale GM. Development of a vaccine for toxoplasmosis: current status. Microbes Infect 2003, 5:457-462. 10.1016/S1286-4579(03)00048-0, 12738002.
13. Clemente M, Curilovic R, Sassone A, Zelada A, Angel SO, Mentaberry AN. Production of the main surface antigen of Toxoplasmagondii in tobacco leaves and analysis of its antigenicity and immunogenicity. Mol Biotechnol 2005, 30:41-50. 10.1385/MB:30:1:041, 15805575.
14. Ferraro G, Becher ML, Angel SO, Zelada A, Mentaberry AN, Clemente M. Efficient expression of a Toxoplasma gondii dense granule Gra4 antigen in tobacco leaves. Exp Parasitol 2008, 120:118-122. 10.1016/j.exppara.2008.06.002, 18588877.
15. Letscher Bru V, Villard O, Risse B, Zauke M, Klein JP, Kien TT. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin 12 against toxoplasmosis in mice. Infect Immun 1998, 66:4503-4506. 108546, 9712808.
16. Haumont M, Delhaye L, Garcia L, Jurado M, Mazza P, Daminet V, Verlant V, Bollen A, Biemans R, Jacquet A. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a Guinea pig model. Infect Immun 2000, 68:4948-4953. 10.1128/IAI.68.9.4948-4953.2000, 101707, 10948109.
17. Nielsen HV, Lauemoller SL, Christiansen L, Buus S, Fomsgaard A, Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 1999, 67:6358-6363. 97042, 10569750.
18. Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000, 181:317-324. 10.1086/315186, 10608781.
19. Petersen E, Henrik VN, Christiansen L, Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protects mice against lethal infection with Toxoplasma gondii. Vaccine 1998, 16:1283-89. 10.1016/S0264-410X(98)00039-5, 9682392.
20. Chen G, Chen H, Guo H, Zheng H. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice. Chin Med J (Engl) 2002, 115:1448-1452.
21. Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW, Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofetal transmission. Vaccine 2003, 21:2813-2820. 10.1016/S0264-410X(03)00163-4, 12798622.
22. Caetano BC, Bruña-Romero O, Fux B, Mendes EA, Penido ML, Gazzinelli RT. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum Gene Ther 2006, 17:415-426. 10.1089/hum.2006.17.415, 16610929.
23. Zhou H, Gu Q, Zhao Q, Zhang J, Cong H, Li Y, Shenyi H. Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol Res 2007, 100:829-835. 10.1007/s00436-006-0341-6, 17058109.
24. Kasper LH, Khan IA, Ely KH, Buelow R, Boothroyd JC. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J Immunol 1992, 148:1493-1498.
25. Nagel SD, Boothroyd JC. The major surface antigen, P30, of Toxoplasma gondii is anchored by a glycolipid. J Biol Chem 1989, 264:5569-5574.
26. Mallory AC, Parks G, Endres MW, Baulcombe D, Bowman LH, Pruss GJ, Vance VB. The amplicon-plus system for high-level expression of transgenes in plants. Nat Biotechnol 2002, 20:622-625. 10.1038/nbt0602-622, 12042869.
27. Voinnet O, Rivas S, Mestre P, Baulcombe D. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J 2003, 33:949-956. 10.1046/j.1365-313X.2003.01676.x, 12609035.
28. Bayne EH, Rakitina DV, Morozov SY, Baulcombe DC. Cell-to-cell movement of potato potexvirus X is dependent on suppression of RNA silencing. Plant J 2005, 44:471-482. 10.1111/j.1365-313X.2005.02539.x, 16236156.
29. Graille M, Stura EA, Bossus M, Muller BH, Letourneur O, Battail-Poirot N, Sibaï G, Gauthier M, Rolland D, Le Du MH, Ducancel F. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. J Mol Biol 2005, 354:447-458. 10.1016/j.jmb.2005.09.028, 16242717.
30. De Rocher EJ, Vargo-Gogola TC, Diehn SH, Green PJ. Direct evidence for rapid degradation of Bacillus thuringiensis toxin mRNA as a cause of poor expression in plants. Plant Physiol 1998, 117:1445-1461. 10.1104/pp.117.4.1445, 34908, 9701600.
31. Gutiérrez RA, MacIntosh GC, Green PJ. Current perspectives on mRNA stability in plants: multiple levels and mechanisms of control. Trends plant Sci 1999, 4:429-438. 10.1016/S1360-1385(99)01484-3, 10529824.
32. Hollams EM, Giles KM, Thomson AM, Leedman PJ. MRNA stability and the control of gene expression: implications for human disease. Neurochem Res 2002, 27:957-980. 10.1023/A:1020992418511, 12462398.
33. Ahmed R, Duncan RF. Translational regulation of Hsp90v RNA. AUG-proximal 5'-untranslated region elements essential for preferential heat shock translation. J Biol Chem 2004, 279:49919-49930. 10.1074/jbc.M404681200, 15347681.
34. Geyer BC, Fletcher SP, Griffin TA, Lopker MJ, Soreq H, Mor TS. Translational control of recombinant human acetylcholinesterase accumulation in plants. BMC Biotechnol 2007, 30:7-27.
35. Suo G, Chen B, Zhang J, Duan Z, He Z, Yao W, Yue C, Dai J. Effects of codon modification on human BMP2 gene expression in tobacco plants. Plant Cell Rep 2006, 25:689-697. 10.1007/s00299-006-0133-6, 16491379.
36. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene. J Gen Virol 2007, 88:1460-1469. 10.1099/vir.0.82718-0, 17412974.
37. Wang L, Webster DE, Campbell AE, Dry IB, Wesselingh SL, Coppel RL. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants. Int J Parasitol 2008, 38:103-110. 10.1016/j.ijpara.2007.06.005, 17681344.
38. Webster DE, Wang L, Mulcair M, Ma C, Santi L, Mason HS, Wesselingh SL, Coppel RL. Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system. Plant Biotechnol J 2009, 7:846-855. 10.1111/j.1467-7652.2009.00447.x, 19781007.
39. Wandelt CI, Khan MR, Craig S, Schroeder HE, Spencer D, Higgins TJ. Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J 1992, 2:181-192.
40. Yoshida K, Matsui T, Shinmyo A. The plant vesicular transport engineering for production of useful recombinant proteins. J Mol Catalysis B: Enzymatic 2004, 28:167-171.
41. Sher A, Collazzo C, Scanga C, Jankovic D, Yap G, Aliberti J. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol Res 2003, 27:521-528. 10.1385/IR:27:2-3:521, 12857995.
42. Harning D, Spenter J, Metsis A, Vuust J, Petersen E. Recombinant Toxoplasma gondii surface Antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol 1996, 3:355-357. 170346, 8705683.
43. Bout DT, Mevelec MN, Velge-Roussel F, Dimier-Poisson I, Lebrun M. Prospects for a human Toxoplasma vaccine. Curr Drug Targets Immune Endocr Metabol Disord 2002, 2:227-234. 10.2174/1568008023340488, 12476487.
44. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 2001, 98:11539-11544. 10.1073/pnas.191617598, 58765, 11553782.
45. Franconi R, Di Bonito P, Dibello F, Accardi L, Muller A, Cirilli A, Simeone P, Donà MG, Venuti A, Giorgi C. Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res 2002, 62:3654-3658.
46. Guerrero-Andrade O, Loza-Rubio E, Olivera-Flores T, Fehervari-Bone T, Gomez-Lim MA. Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res 2006, 15:455-463. 10.1007/s11248-006-0017-0, 16906446.
47. Gómez E, Chimeno Zoth S, Carrillo E, Estela Roux M, Berinstein. Mucosal immunity induced by orally administered transgenic plants. Immunobiology 2008, 213:671-675. 10.1016/j.imbio.2008.02.002, 18950595.
48. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26:1846-1854. 10.1016/j.vaccine.2008.01.053, 2744496, 18325641.
49. Zhang X, Yuan Z, Duan Q, Zhu H, Yu H, Wang Q. Mucosal immunity in mice induced by orally administered transgenic rice. Vaccine 2009, 27:1596-1600. 10.1016/j.vaccine.2008.12.042, 19146896.
50. Matsumoto Y, Suzuki S, Nozoye T, Yamakawa T, Takashima Y, Arakawa T, Tsuji N, Takaiwa F, Hayashi Y. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin Bsubunit. Transgenic Res 2009, 18:185-192. 10.1007/s11248-008-9205-4, 18763047.
51. Mayers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Williamson AL, Rybicki EP. Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnology 2008, 53:1-15.
52. Kostrzak A, Cervantes Gonzalez M, Guetard D, Nagaraju DB, Wain-Hobson S, Tepfer D, Pniewski T, Sala M. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine 2009, 27:4798-4807. 10.1016/j.vaccine.2009.05.092, 19539581.
53. Quintana FJ, Cohen RI. Heat Shock Proteins as Endogenous Adjuvants in Sterile and Septic Inflammation. J Immunol 2005, 175:2777-2782.
54. Dong JL, Liang BG, Jin YS, Zhang WJ, Wang T. Oral immunization with pBpoSP6-transgenic alfalfa protects mice against rotavirus infection. Virology 2005, 339:153-163. 10.1016/j.virol.2005.06.004, 15992851.
55. Zimmermann S, Dalpke A, Heeg K. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. Int J Med Microbiol 2008, 298:39-44. 10.1016/j.ijmm.2007.07.011, 17716944.
56. Sharp PM, Li WH. The codon Adaptation Index-a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res 1987, 15:1281-1295. 10.1093/nar/15.3.1281, 340524, 3547335.
57. Höfgen R, Willmitzer L. Storage of competent cells for Agrobacterium transformation. Nucleic Acids Res 1988, 16:9877. 10.1093/nar/16.20.9877, 338805, 3186459.
58. Kapila J, De Rycke R, van Montagu M, Angenon G. An Agrobacterium-mediated transient gene expression system in intact leaves. Plant Sci 1997, 122:101-108.
59. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor Press.